Search results for: 'cell ad gene manufacturing'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming respiratory medicine, liver regeneration, metabolic disease management, infectious disease therapeutics, neurological disorders, cardiovascular risk reduction, oncology workflows, and nex...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...

This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations cross immunotherapies, precision medicine, cancer treatment, cell engineering, liquid biopsy and AI-enabled drug discovery and development. The TOE also highlights recent advances in implantables, ophthalmology, neurop...

Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environments toward scalable, field-ready systems that meet ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across innovations in precision medicine, targeted drug delivery, RNA editing, biomanufacturing, cell and gene therapies. The research also comprises advances in single cell analysis, hybrid microbots, AI-powered diagnostic, bioprinting and non...